Jump to content

20250206822. Antibodies Bindi (Five Prime Therapeutics, .)

From WikiPatents

Antibodies Binding to Vista at Acidic pH

Abstract: the present application relates to antibodies specifically binding to the v-domain immunoglobulin-containing suppressor of t-cell activation (vista) at acidic ph and their use in cancer treatment. in some embodiments, the antibodies bind specifically to human vista at acidic ph, but do not significantly bind to human vista at neutral or physiological ph.

Inventor(s): Robert J. Johnston, Arvind Rajpal, Paul O. Sheppard, Luis Borges, Andrew Rankin, Keith Sadoon Bahjat, Alan J. Korman, Andy X. Deng, Lin Hui Su, Ginger Rakestraw

CPC Classification: C07K16/2812 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))

Search for rejections for patent application number 20250206822


Cookies help us deliver our services. By using our services, you agree to our use of cookies.